Elmaro restores freedom
Elmaro restores the freedom for cats and dogs to engage in daily adventures without the burden of nausea or vomiting holding them back.
Trusted molecule.
Fast effective relief.
Formulated to reduce injection pain.*
More comfort.
New choice.
More value.
Trusted efficacy of maropitant
Elmaro is a maropitant injectable solution. In veterinary medicine, maropitant has become a molecule of reference.
Maropitant, a centrally acting neurokinin-1 receptor antagonist, is the first drug in its class to be approved to treat and prevent vomiting in cats and dogs. Suitable for both subcutaneous and intravenous use.
Indicated for cats and dogs
Elmaro is indicated to prevent and treat nausea and vomiting in cats and dogs.
Dog- Prevention of vomiting (except that induced by motion sickness)
- Prevention of perioperative nausea and vomiting and improvement in recovery from general anaesthesia after use of morphine
- Treatment and prevention of nausea induced by chemotherapy
- Treatment of vomiting in combination with other supportive measures
Cat- Prevention of vomiting & reduction of nausea (except that induced by motion sickness)
- Treatment of vomiting in combination with other supportive measures
Formulated to reduce injection pain
Elmaro offers a more gentle pet friendly injection, for a smoother consultation.
Its formulation contains benzyl alcohol:*
Known for its local anesthetic properties
Proven to reduce pain at the injection site
Significantly less painful than injection of maropitant with metacresol
*Deckers N et al. Comparison of pain response after subcutaneous injection of two maropitant formulations to beagle dogs. Veterinary Record Open 2018;5:e000262.
